The Role of the Cyclin-dependent Kinase Inhibitor p 21 in Apoptosis 1

Cancer develops when the balance between cell proliferation and cell death is disrupted, and the ensuing aberrant proliferation leads to tumor growth. The cyclin-dependent kinase inhibitor p21 is induced by both p53-dependent and -independent mechanisms following stress, and induction of p21 may cause cell cycle arrest. As a proliferation inhibitor, p21 is poised to play an important role in preventing tumor development. This notion is supported by data indicating that p21-null mice are more prone to spontaneous and induced tumorigenesis, and p21 synergizes with other tumor suppressors to protect against tumor progression in mice. However, a number of recent studies have pointed out that in addition to being an inhibitor of cell proliferation, p21 acts as an inhibitor of apoptosis in a number of systems, and this may counteract its tumor-suppressive functions as a growth inhibitor. In the current review, we discuss the role of p21 in regulating cell death and the potential relevance of its expression in cancer.

[1]  K. Kinzler,et al.  Genetic determinants of p53-induced apoptosis and growth arrest. , 1996, Genes & development.

[2]  N. Hay,et al.  A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function , 2001, Oncogene.

[3]  O. Delattre,et al.  Induction of p21Waf1/Cip1 by TNFα requires NF-κB activity and antagonizes apoptosis in Ewing tumor cells , 2000, Oncogene.

[4]  S. Elledge,et al.  Cdk-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase delta holoenzyme. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[5]  S. Grant,et al.  Induction of apoptosis in U937 human leukemia cells by suberoylanilide hydroxamic acid (SAHA) proceeds through pathways that are regulated by Bcl-2/Bcl-XL, c-Jun, and p21CIP1, but independent of p53 , 1999, Oncogene.

[6]  A. Fornace,et al.  Role of p21Waf1/Cip1/Sdi1 in cell death and DNA repair as studied using a tetracycline-inducible system in p53-deficient cells , 1997, Oncogene.

[7]  R. Bronson,et al.  Deletion of the p27Kip1 gene restores normal development in cyclin D1-deficient mice. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[8]  Asad Umar,et al.  Requirement for PCNA in DNA Mismatch Repair at a Step Preceding DNA Resynthesis , 1996, Cell.

[9]  E. Sage,et al.  Transforming growth factor‐β1 induces apoptotic cell death in cultured retinal endothelial cells but not pericytes: Association with decreased expression of p21waf1/cip1 , 1998, Journal of cellular biochemistry.

[10]  J. Massagué,et al.  Differential Interaction of the Cyclin-dependent Kinase (Cdk) Inhibitor p27Kip1 with Cyclin A-Cdk2 and Cyclin D2-Cdk4* , 1997, The Journal of Biological Chemistry.

[11]  S. Reed,et al.  Molecular cloning, sequencing, chromosomal localization and expression of mouse p21 (Waf1). , 1994, Oncogene.

[12]  J. Pollard,et al.  Genetic Evidence for the Interactions of Cyclin D1 and p27Kip1 in Mice , 2001, Molecular and Cellular Biology.

[13]  G. Hannon,et al.  The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA , 1994, Nature.

[14]  M. Roussel,et al.  Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1). , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[15]  R. Hingorani,et al.  CD95/Fas Signaling in T Lymphocytes Induces the Cell Cycle Control Protein p21cip-1/WAF-1, Which Promotes Apoptosis1 , 2000, The Journal of Immunology.

[16]  L. Ignarro,et al.  Role of p42/p44 mitogen-activated-protein kinase and p21waf1/cip1 in the regulation of vascular smooth muscle cell proliferation by nitric oxide , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[17]  D. Banerjee,et al.  Overexpression of p21(waf1) decreases G2-M arrest and apoptosis induced by paclitaxel in human sarcoma cells lacking both p53 and functional Rb protein. , 1999, Molecular pharmacology.

[18]  H. Saya,et al.  A point mutation of human p53, which was not detected as a mutation by a yeast functional assay, led to apoptosis but not p21Waf1/Cip1/Sdi1 expression in response to ionizing radiation in a human osteosarcoma cell line, Saos-2. , 1999, International journal of radiation oncology, biology, physics.

[19]  K. Kinzler,et al.  Disruption of p53 in human cancer cells alters the responses to therapeutic agents. , 1999, The Journal of clinical investigation.

[20]  E. Nabel,et al.  The p21 cyclin–dependent kinase inhibitor suppresses tumorigenicity in vivo , 1995, Nature Medicine.

[21]  A. Sewing,et al.  Cyclins D1 and D2 mediate Myc‐induced proliferation via sequestration of p27Kip1 and p21Cip1 , 1999, The EMBO journal.

[22]  E. Wagner,et al.  The Mammalian UV Response c-Jun Induction Is Required for Exit from p53-Imposed Growth Arrest , 2000, Cell.

[23]  M. Weller,et al.  Identification of p21 as a target of cycloheximide-mediated facilitation of CD95-mediated apoptosis in human malignant glioma cells , 2001, Oncogene.

[24]  M. Miura,et al.  Caspase 3 inactivation to suppress Fas-mediated apoptosis: identification of binding domain with p21 and ILP and inactivation machinery by p21 , 1999, Oncogene.

[25]  R. Coffey,et al.  Antioxidants enhance the cytotoxicity of chemotherapeutic agents in colorectal cancer: A p53-independent induction of p21WAF1/CIP1 via C/EBPβ , 1997, Nature Medicine.

[26]  C. Kemp,et al.  Tumor suppression by p27Kip1 and p21Cip1 during chemically induced skin carcinogenesis , 1999, Oncogene.

[27]  M. Gorospe,et al.  Protective role of p21(Waf1/Cip1) against prostaglandin A2-mediated apoptosis of human colorectal carcinoma cells , 1996, Molecular and cellular biology.

[28]  James M. Roberts,et al.  Cleavage of p21Cip1/Waf1 and p27Kip1 mediates apoptosis in endothelial cells through activation of Cdk2: role of a caspase cascade. , 1998, Molecular cell.

[29]  Jeffrey E. Green,et al.  Suppression of mammary carcinoma growth in vitro and in vivo by inducible expression of the Cdk inhibitor p21 , 2001, Cancer Gene Therapy.

[30]  T. Tsurimoto PCNA binding proteins. , 1999, Frontiers in bioscience : a journal and virtual library.

[31]  M. Serrano,et al.  The cell cycle inhibitor p21 controls T-cell proliferation and sex-linked lupus development , 2000, Nature Medicine.

[32]  D. Johnson,et al.  p21WAF1 Prevents Down-modulation of the Apoptotic Inhibitor Protein c-IAP1 and Inhibits Leukemic Apoptosis , 2000, Molecular medicine.

[33]  D. Lukovic,et al.  Caspase-Dependent Cdk Activity Is a Requisite Effector of Apoptotic Death Events , 2000, The Journal of cell biology.

[34]  G. Bren,et al.  IκB Kinase-Dependent Chronic Activation of NF-κB Is Necessary for p21WAF1/Cip1 Inhibition of Differentiation-Induced Apoptosis of Monocytes , 2001, Molecular and Cellular Biology.

[35]  F. Kashanchi,et al.  Overexpression of p21waf1 in Human T-Cell Lymphotropic Virus Type 1-Infected Cells and Its Association with Cyclin A/cdk2 , 2000, Journal of Virology.

[36]  R. Coffey,et al.  Pyrrolidinedithiocarbamate increases the therapeutic index of 5-fluorouracil in a mouse model. , 2000, Gastroenterology.

[37]  J. Massagué,et al.  Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. , 1995, Genes & development.

[38]  K. Kinzler,et al.  Achilles' heel of cancer? , 2001, Nature.

[39]  N. Donato,et al.  Tumor Necrosis Factor-induced Apoptosis Stimulates p53 Accumulation and p21WAF1 Proteolysis in ME-180 Cells* , 1998, The Journal of Biological Chemistry.

[40]  Jun Yao,et al.  Overexpression of ErbB2 blocks Taxol-induced apoptosis by upregulation of p21Cip1, which inhibits p34Cdc2 kinase. , 1998, Molecular cell.

[41]  S. Elledge,et al.  p21(CIP1) and p57(KIP2) control muscle differentiation at the myogenin step. , 1999, Genes & development.

[42]  A. Suzuki,et al.  Mitochondrial Regulation of Cell Death: Mitochondria Are Essential for Procaspase 3-p21 Complex Formation To Resist Fas-Mediated Cell Death , 1999, Molecular and Cellular Biology.

[43]  Stephen J. Elledge,et al.  Mice Lacking p21 CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control , 1995, Cell.

[44]  M. Miura,et al.  Resistance to Fas-mediated apoptosis: activation of Caspase 3 is regulated by cell cycle regulator p21WAF1 and IAP gene family ILP , 1998, Oncogene.

[45]  J. Pietenpol,et al.  Defective G1-S cell cycle checkpoint function sensitizes cells to microtubule inhibitor-induced apoptosis. , 1999, Cancer research.

[46]  P. Pandolfi,et al.  Targeted Disruption of CDK4 Delays Cell Cycle Entry with Enhanced p27Kip1 Activity , 1999, Molecular and Cellular Biology.

[47]  M. Hung,et al.  Overexpression of c-erbB-2/neu in breast cancer cells confers increased resistance to Taxol via mdr-1-independent mechanisms. , 1996, Oncogene.

[48]  B. Brüne,et al.  Modulation of nitric oxide‐evoked apoptosis by the p53‐downstream target p21WAF1/CIP1 , 2000, Journal of leukocyte biology.

[49]  B. Howard,et al.  WAF1 retards S-phase progression primarily by inhibition of cyclin-dependent kinases , 1997, Molecular and cellular biology.

[50]  J. LaBaer,et al.  New functional activities for the p21 family of CDK inhibitors. , 1997, Genes & development.

[51]  K. Roemer,et al.  p21 Waf1/Cip1 can protect human colon carcinoma cells against p53-dependent and p53-independent apoptosis induced by natural chemopreventive and therapeutic agents , 2001, Oncogene.

[52]  M. Hung,et al.  Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells , 2001, Nature Cell Biology.

[53]  P. Subramaniam,et al.  IFN-gamma induction of p21(WAF1) is required for cell cycle inhibition and suppression of apoptosis. , 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[54]  T. Jorgensen,et al.  p21WAF1/CIP1 antisense therapy radiosensitizes human colon cancer by converting growth arrest to apoptosis. , 2000, Cancer research.

[55]  M. Gorospe,et al.  Up-regulation and functional role of p21Waf1/Cip1 during growth arrest of human breast carcinoma MCF-7 cells by phenylacetate. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[56]  J. Jorcano,et al.  The ink4a/arf Tumor Suppressors Cooperate with p21 cip1/waf in the Processes of Mouse Epidermal Differentiation, Senescence, and Carcinogenesis* , 2001, The Journal of Biological Chemistry.

[57]  M. Kastan,et al.  Growth factor modulation of p53-mediated growth arrest versus apoptosis. , 1995, Genes & development.

[58]  S. Pavey,et al.  Up-regulation of p21(WAF1/CIP1) by histone deacetylase inhibitors reduces their cytotoxicity. , 2001, Molecular pharmacology.

[59]  Charles J. Sherr,et al.  Mammalian G1 cyclins , 1993, Cell.

[60]  John Calvin Reed,et al.  Effect of p21waf1/cip1 transgene on radiation induced apoptosis in T cells , 1999, Oncogene.

[61]  J. Megyesi,et al.  The lack of a functional p21WAF1/CIP1 gene ameliorates progression to chronic renal failure , 1999 .

[62]  M. Kaneuchi,et al.  Induction of apoptosis by the p53‐273L (Arg→Leu) mutant in HSC3 cells without transactivation of p21Waf1/Cip1/Sdi1 and bax , 1999, Molecular carcinogenesis.

[63]  K. K. Kim,et al.  Overexpressed human RAD50 exhibits cell death in a p21(WAF1/CIP1)-dependent manner: its potential utility in local gene therapy of tumor. , 2001, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[64]  S. Elledge,et al.  Inhibition of cyclin-dependent kinases by p21. , 1995, Molecular biology of the cell.

[65]  P. Howley,et al.  Ubiquitination of p53 and p21 is differentially affected by ionizing and UV radiation , 1997, Molecular and cellular biology.

[66]  S. Horwitz,et al.  Mechanism of action of taxol. , 1992, Trends in pharmacological sciences.

[67]  M. Kirschner,et al.  Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA , 1995, Nature.

[68]  D. Conrad,et al.  Dysregulation of the cyclin-dependent kinase inhibitor p21WAF1/CIP1/MDA6 increases the susceptibility of human leukemia cells (U937) to 1-beta-D-arabinofuranosylcytosine-mediated mitochondrial dysfunction and apoptosis. , 1999, Cancer research.

[69]  M. Nakanishi,et al.  A degradation signal located in the C‐terminus of p21WAF1/CIP1 is a binding site for the C8 α‐subunit of the 20S proteasome , 2001, The EMBO journal.

[70]  G. Hannon,et al.  Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD , 1995, Science.

[71]  J. Uhr,et al.  Cancer dormancy and cell signaling: induction of p21(waf1) initiated by membrane IgM engagement increases survival of B lymphoma cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[72]  M. O’Reilly,et al.  p53-dependent induction of p21(Cip1/WAF1/Sdi1) protects against oxygen-induced toxicity. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.

[73]  D. Givol,et al.  Induced p21waf expression in H1299 cell line promotes cell senescence and protects against cytotoxic effect of radiation and doxorubicin , 1999, Oncogene.

[74]  Prem Seth,et al.  Cleavage of CDK Inhibitor p21Cip1/Waf1 by Caspases Is an Early Event during DNA Damage-induced Apoptosis* , 1998, The Journal of Biological Chemistry.

[75]  A. Gartel,et al.  p21—Negative Regulator of the Cell Cycle , 1996, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[76]  J. Hurwitz,et al.  Inhibition of Nucleotide Excision Repair by the Cyclin-dependent Kinase Inhibitor p21 (*) , 1995, The Journal of Biological Chemistry.

[77]  M. Andreeff,et al.  Overexpressed WAF1/Cip1 renders glioblastoma cells resistant to chemotherapy agents 1,3-bis(2-chloroethyl)-1-nitrosourea and cisplatin. , 1998, Cancer research.

[78]  R. Weiss,et al.  p21(Waf1/Cip1) is an assembly factor required for platelet-derived growth factor-induced vascular smooth muscle cell proliferation. , 2000, The Journal of biological chemistry.

[79]  S. Lowe,et al.  Transcriptional activation by p53, but not induction of the p21 gene, is essential for oncogene‐mediated apoptosis. , 1996, The EMBO journal.

[80]  S. Adimoolam,et al.  The p53-regulated Cyclin-dependent Kinase Inhibitor, p21 (cip1, waf1, sdi1), Is Not Required for Global Genomic and Transcription-coupled Nucleotide Excision Repair of UV-induced DNA Photoproducts* , 2001, The Journal of Biological Chemistry.

[81]  S. Elledge,et al.  p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells , 1995, Science.

[82]  J. Megyesi,et al.  The lack of a functional p21(WAF1/CIP1) gene ameliorates progression to chronic renal failure. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[83]  K. Kinzler,et al.  Cooperative effects of genes controlling the G(2)/M checkpoint. , 2000, Genes & development.

[84]  P. Leder,et al.  Loss of p21 increases sensitivity to ionizing radiation and delays the onset of lymphoma in atm-deficient mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[85]  M. Lawlor,et al.  Insulin-Like Growth Factor-Mediated Muscle Cell Survival: Central Roles for Akt and Cyclin-Dependent Kinase Inhibitor p21 , 2000, Molecular and Cellular Biology.

[86]  K Watanabe,et al.  Effects of p21Waf1/Cip1/Sdi1 on cellular gene expression: implications for carcinogenesis, senescence, and age-related diseases. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[87]  Bert Vogelstein,et al.  Cell-cycle arrest versus cell death in cancer therapy , 1997, Nature Medicine.

[88]  R. Weiss,et al.  p21Waf1/Cip1 Is an Assembly Factor Required for Platelet-derived Growth Factor-induced Vascular Smooth Muscle Cell Proliferation* , 2000, The Journal of Biological Chemistry.

[89]  J. Massagué,et al.  Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1 , 1995, Nature.

[90]  D. Stacey,et al.  Prostaglandin A Blocks the Activation of G Phase Cyclin-dependent Kinase without Altering Mitogen-activated Protein Kinase Stimulation (*) , 1996, The Journal of Biological Chemistry.

[91]  A. Gartel,et al.  Transcriptional regulation of the p21((WAF1/CIP1)) gene. , 1999, Experimental cell research.

[92]  C. Sherr The Pezcoller lecture: cancer cell cycles revisited. , 2000, Cancer research.

[93]  G. Peters,et al.  Induced Expression of p16INK4a Inhibits Both CDK4- and CDK2-Associated Kinase Activity by Reassortment of Cyclin-CDK-Inhibitor Complexes , 1999, Molecular and Cellular Biology.

[94]  Pier Paolo Pandolfi,et al.  The p66shc adaptor protein controls oxidative stress response and life span in mammals , 1999, Nature.

[95]  K. Miyazono,et al.  Apoptosis inhibitory activity of cytoplasmic p21Cip1/WAF1 in monocytic differentiation , 1999, The EMBO journal.

[96]  J. Roth,et al.  Induction of differentiation-dependent apoptosis in human esophageal squamous cell carcinoma by adenovirus-mediated p21sdi1 gene transfer. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[97]  Ying Li,et al.  AKT/PKB Phosphorylation of p21Cip/WAF1 Enhances Protein Stability of p21Cip/WAF1 and Promotes Cell Survival* , 2002, The Journal of Biological Chemistry.

[98]  V. Godfrey,et al.  Functional Collaboration between Different Cyclin-Dependent Kinase Inhibitors Suppresses Tumor Growth with Distinct Tissue Specificity , 2000, Molecular and Cellular Biology.

[99]  J. A. Ross,et al.  Triptolide and Chemotherapy Cooperate in Tumor Cell Apoptosis , 2001, The Journal of Biological Chemistry.

[100]  J. Gulbis,et al.  The Influence of the Proliferating Cell Nuclear Antigen-interacting Domain of p21CIP1 on DNA Synthesis Catalyzed by the Human and Saccharomyces cerevisiae Polymerase δ Holoenzymes* , 1997, The Journal of Biological Chemistry.

[101]  K. Kinzler,et al.  p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. , 1995, Genes & development.

[102]  V. Bohr,et al.  The C-terminal domain of p21 inhibits nucleotide excision repair In vitro and In vivo. , 1999, Molecular biology of the cell.

[103]  H. Kim,et al.  Galectin-3 mediates genistein-induced G(2)/M arrest and inhibits apoptosis. , 2000, Carcinogenesis.

[104]  M. Herlyn,et al.  The administration schedule of cyclin-dependent kinase inhibitor gene therapy and etoposide chemotherapy is a major determinant of cytotoxicity. , 1999, International journal of oncology.

[105]  G. Hannon,et al.  p21-containing cyclin kinases exist in both active and inactive states. , 1994, Genes & development.

[106]  V. Wee Yong,et al.  Involvement of p21Waf1/Cip1 in Protein Kinase C Alpha-Induced Cell Cycle Progression , 2000, Molecular and Cellular Biology.

[107]  D. Chattopadhyay,et al.  Inactivation of p21 by E1A Leads to the Induction of Apoptosis in DNA-Damaged Cells , 2001, Journal of Virology.

[108]  D. Beach,et al.  Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes. , 1993, Molecular biology of the cell.

[109]  James M. Roberts,et al.  Cloning of p27 Kip1 , a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals , 1994, Cell.

[110]  M. Comalada,et al.  Decorin inhibits macrophage colony-stimulating factor proliferation of macrophages and enhances cell survival through induction of p27(Kip1) and p21(Waf1). , 2001, Blood.

[111]  G. Casey,et al.  WAF1/CIP1 increases the susceptibility of p53 non-functional malignant glioma cells to cisplatin-induced apoptosis. , 1996, Oncogene.

[112]  Hui Zhang,et al.  D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA , 1992, Cell.

[113]  W. J. Pledger,et al.  Analysis of Cyclin D3-cdk4 Complexes in Fibroblasts Expressing and Lacking p27kip1 and p21cip1 , 2000, Molecular and Cellular Biology.

[114]  Yiwei Li,et al.  Induction of apoptosis in breast cancer cells MDA-MB-231 by genistein , 1999, Oncogene.

[115]  James M. Roberts,et al.  p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. , 1994, Genes & development.

[116]  G. Wahl,et al.  A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage. , 1996, Genes & development.

[117]  J. Trent,et al.  WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.

[118]  Stephen J. Elledge,et al.  p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest , 1994, Cell.

[119]  P. Roberson,et al.  Transcriptional Activation of the p21 WAF1,CIP1,SDI1 Gene by Interleukin-6 Type Cytokines , 1998, The Journal of Biological Chemistry.

[120]  J. Hsieh,et al.  Adenovirus-Mediated p21(WAF1/SDII/CIP1)Gene Transfer Induces Apoptosis of Human Cervical Cancer Cell Lines , 1999, Journal of Virology.

[121]  S. Elledge,et al.  p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. , 1995, Genes & development.

[122]  K. Walsh,et al.  Resistance to Apoptosis Conferred by Cdk Inhibitors During Myocyte Differentiation , 1996, Science.

[123]  T. Jacks,et al.  p21 Is a Critical CDK2 Regulator Essential for Proliferation Control in Rb-deficient Cells , 1998, The Journal of cell biology.

[124]  K. Naka,et al.  Effect of trichostatin A on cell growth and expression of cell cycle‐ and apoptosis‐related molecules in human gastric and oral carcinoma cell lines , 2000, International journal of cancer.

[125]  Tony Hunter,et al.  p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21 , 1994, Cell.

[126]  G. Hannon,et al.  Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair , 1994, Nature.

[127]  A. Evdokiou,et al.  Involvement of p21(Waf1/Cip1) and its cleavage by DEVD-caspase during apoptosis of colorectal cancer cells induced by butyrate. , 2000, Carcinogenesis.

[128]  S. Hsu,et al.  Induction of p21(CIP1/Waf1) and activation of p34(cdc2) involved in retinoic acid-induced apoptosis in human hepatoma Hep3B cells. , 1999, Experimental cell research.

[129]  D. Scadden,et al.  Hematopoietic stem cell quiescence maintained by p21cip1/waf1. , 2000, Science.

[130]  D. Feyes,et al.  Resveratrol causes WAF-1/p21-mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[131]  A. Gartel,et al.  p21 (WAF1/CIP1) expression is induced in newly nondividing cells in diverse epithelia and during differentiation of the Caco-2 intestinal cell line. , 1996, Experimental cell research.

[132]  W. McGuire,et al.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. , 1987, Science.

[133]  N. Senzer,et al.  Virus-mediated killing of cells that lack p53 activity. , 2001, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[134]  W. El-Deiry,et al.  Repair defect in p21WAF1/CIP1 -/- human cancer cells , 1996 .

[135]  U. Strausfeld,et al.  Cip1 inhibits DNA replication but not PCNA-dependent nucleotide excision—repair , 1994, Current Biology.

[136]  D. Hunting,et al.  p21-induced cycle arrest in G1 protects cells from apoptosis induced by UV-irradiation or RNA polymerase II blockage , 1998, Oncogene.

[137]  James M. Roberts,et al.  The p21Cip1 and p27Kip1 CDK ‘inhibitors’ are essential activators of cyclin D‐dependent kinases in murine fibroblasts , 1999, The EMBO journal.

[138]  W. Ansorge,et al.  Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27 , 1999, The EMBO journal.

[139]  M. Ikeda,et al.  Cyclin A/cdk2 Activation Is Involved in Hypoxia-Induced Apoptosis in Cardiomyocytes , 2001, Circulation research.

[140]  Z. Fan,et al.  Protection against chemotherapy-induced cytotoxicity by cyclin-dependent kinase inhibitors (CKI) in CKI-responsive cells compared with CKI-unresponsive cells , 2001, Oncogene.

[141]  W. El-Deiry,et al.  Pioglitazone Inhibits Growth of Carcinoid Cells and Promotes TRAIL-Induced Apoptosis by Induction of p21waf1/cip1 , 2001, Digestion.

[142]  J. Cairncross,et al.  Inactivation of p53 sensitizes U87MG glioma cells to 1,3-bis(2-chloroethyl)-1-nitrosourea. , 2001, Cancer research.

[143]  A. Giaccia,et al.  Loss of p21Waf1/Cip1 sensitizes tumors to radiation by an apoptosis-independent mechanism. , 1997, Cancer research.

[144]  Xinbin Chen,et al.  The potential tumor suppressor p73 differentially regulates cellular p53 target genes. , 1998, Cancer research.

[145]  James M. Roberts,et al.  CDK inhibitors: positive and negative regulators of G1-phase progression. , 1999, Genes & development.

[146]  W. El-Deiry,et al.  Repair Defect in p21 WAF1/CIP1 -/- human cancer cells. , 1996, Cancer research.

[147]  B. Clurman,et al.  Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination. , 2000, Molecular cell.

[148]  K. Kinzler,et al.  Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues. , 1995, Cancer research.

[149]  H. Lincet,et al.  The p21(cip1/waf1) cyclin-dependent kinase inhibitor enhances the cytotoxic effect of cisplatin in human ovarian carcinoma cells. , 2000, Cancer letters.

[150]  M. Serrano,et al.  Tumor susceptibility of p21(Waf1/Cip1)-deficient mice. , 2001, Cancer research.

[151]  Xin Lu,et al.  ASPP proteins specifically stimulate the apoptotic function of p53. , 2001, Molecular cell.

[152]  Ying-hua Jin,et al.  Caspase 3-mediated Cleavage of p21 WAF1/CIP1 Associated with the Cyclin A-Cyclin-dependent Kinase 2 Complex Is a Prerequisite for Apoptosis in SK-HEP-1 Cells* , 2000, The Journal of Biological Chemistry.

[153]  G. Evan,et al.  Proliferation, cell cycle and apoptosis in cancer , 2001, Nature.

[154]  S. Nicosia,et al.  Loss of p21WAF1/CIP1 accelerates Ras oncogenesis in a transgenic/knockout mammary cancer model , 2000, Oncogene.

[155]  A. Ross,et al.  The cyclin-dependent kinase inhibitor p21 (WAF1) is required for survival of differentiating neuroblastoma cells , 1996, Molecular and cellular biology.

[156]  G. Dotto,et al.  p21(WAF1/Cip1) functions as a suppressor of malignant skin tumor formation and a determinant of keratinocyte stem-cell potential. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[157]  R. Bambara,et al.  Regulatory Roles of p21 and Apurinic/Apyrimidinic Endonuclease 1 in Base Excision Repair* , 2001, The Journal of Biological Chemistry.

[158]  A. Deblasio,et al.  Formation of p27-CDK complexes during the human mitotic cell cycle. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[159]  L. Hengst,et al.  Effects of p21Cip1/Waf1 at Both the G1/S and the G2/M Cell Cycle Transitions: pRb Is a Critical Determinant in Blocking DNA Replication and in Preventing Endoreduplication , 1998, Molecular and Cellular Biology.

[160]  J. Mendelsohn,et al.  Differential modulation of paclitaxel-mediated apoptosis by p21Waf1 and p27Kip1 , 2000, Oncogene.

[161]  W. El-Deiry,et al.  p21(WAF1/CIP1) inhibits initiator caspase cleavage by TRAIL death receptor DR4. , 2000, Biochemical and biophysical research communications.

[162]  James Brugarolas,et al.  Radiation-induced cell cycle arrest compromised by p21 deficiency , 1995, Nature.

[163]  David O. Morgan,et al.  Principles of CDK regulation , 1995, Nature.

[164]  J. Testa,et al.  Cell Cycle Withdrawal Promotes Myogenic Induction of Akt, a Positive Modulator of Myocyte Survival , 1999, Molecular and Cellular Biology.

[165]  J. Xaus,et al.  Interferon gamma induces the expression of p21waf-1 and arrests macrophage cell cycle, preventing induction of apoptosis. , 1999, Immunity.

[166]  W. H. Kim,et al.  p21 promotes ceramide-induced apoptosis and antagonizes the antideath effect of Bcl-2 in human hepatocarcinoma cells. , 1999, Experimental cell research.

[167]  M. Tatsuka,et al.  Involvement of cyclin‐dependent kinases in doxorubicin‐induced apoptosis in human tumor cells , 2000, Molecular carcinogenesis.

[168]  David Beach,et al.  p21 is a universal inhibitor of cyclin kinases , 1993, Nature.

[169]  S. Elledge,et al.  The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases , 1993, Cell.

[170]  H. Um,et al.  Constitutive hyperexpression of p21(WAF1) in human U266 myeloma cells blocks the lethal signaling induced by oxidative stress but not by Fas. , 2001, Biochemical and biophysical research communications.

[171]  M. Gorospe,et al.  p21Waf1/Cip1 protects against p53-mediated apoptosis of human melanoma cells , 1997, Oncogene.

[172]  T. Tsuruo,et al.  Caspase-mediated cleavage of p21Waf1/Cip1 converts cancer cells from growth arrest to undergoing apoptosis , 1999, Oncogene.

[173]  J. R. Smith,et al.  Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. , 1994, Experimental cell research.

[174]  Wenyi Wei,et al.  Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. , 1997, Science.